SPOTLIGHT -
A brief discussion of dose increase versus unchanged continuation of antidepressants after initial treatment failure in patients with depression.
Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms
Blue Light Blockers: A Behavior Therapy for Mania
Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder
Treating ‘Morally Objectionable’ Patients
CRP as a Biomarker of Antidepressant Efficacy
How to Navigate and Treat ‘New Year Depression’ in Your Patients